Stay updated on Imetelstat Activity in JAK-Inhibitor-Treated MF Clinical Trial
Sign up to get notified when there's something new on the Imetelstat Activity in JAK-Inhibitor-Treated MF Clinical Trial page.

Latest updates to the Imetelstat Activity in JAK-Inhibitor-Treated MF Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.0%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study information regarding the efficacy and safety of imetelstat for myelofibrosis, while adding new identifiers and a revision update.SummaryDifference14%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
- Check66 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.8%
- Check88 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference0.8%
Stay in the know with updates to Imetelstat Activity in JAK-Inhibitor-Treated MF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Imetelstat Activity in JAK-Inhibitor-Treated MF Clinical Trial page.